Skip to main content
FDA grants HUD designation for Novocure's TTFields delivery system

Novocure has obtained a humanitarian use device designation from the FDA for its Tumor Treating Fields delivery system for use in treating pleural mesothelioma. The company intends to apply for a humanitarian device exemption for the system after it gathers data from the Stellar Phase II pilot trial next year.

Full Story: